An observational, cohort study analyzing effectiveness of the BNT162b2 among Adolescents with Juvenile-onset Inflammatory Rheumatic Diseases
Latest Information Update: 12 Aug 2022
At a glance
- Drugs Tozinameran (Primary)
- Indications COVID 2019 infections
- Focus Therapeutic Use
Most Recent Events
- 12 Aug 2022 New trial record
- 03 Aug 2022 Results published in the Rheumatology